Related Experiment Video
Updated: Jul 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006
Andrew P Steenhoff1, Sarah M Wood, Richard M Rutstein
1Division of Special Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. steenhoff@email.chop.edu
Insights
Invasive pneumococcal disease (IPD) incidence decreased in HIV-infected children after highly active antiretroviral therapy (HAART) introduction. Further monitoring is needed to assess the impact of the heptavalent pneumococcal conjugate vaccine (PCV7) on IPD in this population.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- The heptavalent pneumococcal conjugate vaccine (PCV7) has reduced invasive pneumococcal disease (IPD) in the general pediatric population.
- Limited data exist on IPD trends in children with human immunodeficiency virus (HIV).
Purpose of the Study:
- To investigate the incidence and characteristics of IPD in perinatally HIV-infected children.
- To evaluate the impact of highly active antiretroviral therapy (HAART) and PCV7 on IPD rates in this cohort.
Main Methods:
- A retrospective study analyzing diagnostic codes and laboratory records for IPD cases in children (<18 years) at an urban HIV clinic from 1989 to 2006.
- IPD incidence rates were calculated, and serotype distribution and antibiotic resistance patterns were analyzed.
Main Results:
- A total of 256 children were followed for 1756 person-years, with 21 IPD episodes observed.
- IPD incidence significantly decreased by 84% after HAART introduction (1862/100,000 PY to 292/100,000 PY).
- Following PCV7 introduction, a non-significant increase in IPD incidence was noted (292/100,000 PY to 860/100,000 PY).
Conclusions:
- HAART significantly reduced IPD incidence in perinatally HIV-infected children.
- The effect of PCV7 on IPD in this vulnerable population requires ongoing surveillance.
- Antibiotic resistance to penicillin and trimethoprim-sulfamethoxazole remains a concern.
Objective:
The heptavalent pneumococcal conjugate vaccine (PCV7) has decreased the incidence of pediatric invasive pneumococcal disease (IPD) in the United States. Few data exist on the changing IPD incidence in HIV-infected children.
Methods:
Diagnostic codes and clinical microbiology laboratory records identified cases of IPD from 1989 to 2006 in perinatally-infected children <18 years of age followed at an urban HIV clinic. IPD incidence was calculated and serotype distribution and antibiotic resistance were recorded.
Results:
Two-hundred fifty-six patients were followed for 1756 person-years (PY). The sample was 59% female, 76% black, 14% white, and 8% Hispanic. Of 21 episodes of IPD (1200/100,000 PY), 17 (81%) were female. IPD cases had a median age of 6.3 years (interquartile range [IQR]: 2.3-9.9 years), median CD4% of 17% (IQR: 11-28%), and median CD4 count of 415 cells/mm (range, 2-1699 cells/mm). Bacteremia was the commonest form of IPD (19 episodes; 1080/100,000 PY). After HAART introduction in 1996, the incidence of IPD decreased 84% from 1862/100,000 PY in 1989-1995 to 292/100,000 PY in 1997-1999 (incidence rate ratio [IRR]: 0.16, P = 0.03). After PCV7 introduction in 2000, IPD incidence showed a nonsignificant increase from 292 of 100,000 PY in 1997-1999 to 860 of 100,000 PY in 2001-2006 (IRR: 2.94; P = 0.16). The percentages of IPD isolates nonsusceptible to penicillin and trimethoprim-sulfamethoxazole were 19% and 33%, respectively. Vaccine serotypes accounted for 38% of isolates, vaccine-related 14%, nonvaccine 33%, and the serotype was unknown in 14%.
Conclusions:
The incidence of IPD among perinatally HIV-infected children decreased after the introduction of HAART. Ongoing monitoring is required to determine the effect of PCV7 on IPD in this vulnerable population.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis
Respiratory Syncytial Virus Disease
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Cytomegalovirus Disease

